Skip to main content
Erschienen in: Cancer Causes & Control 8/2009

01.10.2009 | Original paper

Neighborhood socioeconomic status influences the survival of elderly patients with myelodysplastic syndromes in the United States

verfasst von: Rong Wang, Cary P. Gross, Stephanie Halene, Xiaomei Ma

Erschienen in: Cancer Causes & Control | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Abstract

The potential role of socioeconomic status (SES) in the survival of patients with myelodysplastic syndromes (MDS) has not been evaluated. We conducted the first study to assess the prognostic role of neighborhood SES among a cohort of 2,118 patients (age ≥ 66 years) who were diagnosed with incident MDS in the United States during 2001–2002. Principal component analysis was used to develop a summary SES score by combining multiple measures of neighborhood SES. The score was then used to classify the census tract each patient resided in into a category of high, medium, or low SES. Hazard ratios (HRs) were estimated using multivariate Cox proportional hazard models. After adjusting for age, gender, comorbidities, and histological subtypes, compared with MDS patients lived in high-SES census tracts, those resided in medium (HR = 1.14, 95% CI: 1.01–1.30) and low (HR = 1.17, 95% CI: 1.02–1.34) SES census tracts had significantly increased the risks of death. The impact of SES on survival was more apparent for patients with refractory anemia with ringed sideroblasts—patients residing in medium (HR = 1.85, 95% CI: 1.17–2.91) and low (HR = 2.06, 95% CI: 1.27–3.37) census tracts had a nearly two-fold increased the risk of mortality, compared with those living in high-SES census tracts. In conclusion, this population-based study suggests that neighborhood SES status is a significant and independent determinant of survival among elderly patients with MDS in the United States.
Literatur
2.
Zurück zum Zitat Kogevinas M, Pearce N, Susser M, et al (eds) (1997) Social inequalities and cancer, IARC Sci Publ No 138. International Agency for Research on Cancer, Lyon, pp 1–15 Kogevinas M, Pearce N, Susser M, et al (eds) (1997) Social inequalities and cancer, IARC Sci Publ No 138. International Agency for Research on Cancer, Lyon, pp 1–15
4.
Zurück zum Zitat Kirby JB, Kaneda T (2005) Neighborhood socioeconomic disadvantage and access to health care. J Health Soc Behav 46:15–31PubMedCrossRef Kirby JB, Kaneda T (2005) Neighborhood socioeconomic disadvantage and access to health care. J Health Soc Behav 46:15–31PubMedCrossRef
6.
Zurück zum Zitat Byers TE, Wolf HJ, Bauer KR et al (2008) The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study. Cancer 113:582–591. doi:10.1002/cncr.23567 PubMedCrossRef Byers TE, Wolf HJ, Bauer KR et al (2008) The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study. Cancer 113:582–591. doi:10.​1002/​cncr.​23567 PubMedCrossRef
9.
Zurück zum Zitat Roswall N, Olsen A, Christensen J, Rugbjerg K, Mellemkjaer L (2008) Social inequality and incidence of and survival from Hodgkin lymphoma, non-Hodgkin lymphoma and leukaemia in a population-based study in Denmark, 1994–2003. Eur J Cancer 44:2058–2073. doi:10.1016/j.ejca.2008.06.011 PubMedCrossRef Roswall N, Olsen A, Christensen J, Rugbjerg K, Mellemkjaer L (2008) Social inequality and incidence of and survival from Hodgkin lymphoma, non-Hodgkin lymphoma and leukaemia in a population-based study in Denmark, 1994–2003. Eur J Cancer 44:2058–2073. doi:10.​1016/​j.​ejca.​2008.​06.​011 PubMedCrossRef
10.
Zurück zum Zitat Wang M, Burau KD, Fang S, Wang H, Du XL (2008) Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma. Cancer 113:3231–3241. doi:10.1002/cncr.23914 PubMedCrossRef Wang M, Burau KD, Fang S, Wang H, Du XL (2008) Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma. Cancer 113:3231–3241. doi:10.​1002/​cncr.​23914 PubMedCrossRef
12.
13.
Zurück zum Zitat Bennett J (2002) The myelodysplastic syndromes: pathobiology and clinical management. In: Cheson B (ed) Basic and Clinical Oncology, vol 27. Marcel Dekker, New York Bennett J (2002) The myelodysplastic syndromes: pathobiology and clinical management. In: Cheson B (ed) Basic and Clinical Oncology, vol 27. Marcel Dekker, New York
14.
Zurück zum Zitat Greenberg P, Cox C, LeBeau MM et al (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079–2088PubMed Greenberg P, Cox C, LeBeau MM et al (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079–2088PubMed
15.
Zurück zum Zitat Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40: IV-3–18 Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40: IV-3–18
16.
Zurück zum Zitat Fritz A (ed) (2000) International classification of diseases for oncology, 3rd edn. World Health Organization, Geneva Fritz A (ed) (2000) International classification of diseases for oncology, 3rd edn. World Health Organization, Geneva
20.
Zurück zum Zitat Keating NL, Landrum MB, Meara E, Ganz PA, Guadagnoli E (2005) Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector? J Natl Cancer Inst 97:257–264PubMedCrossRef Keating NL, Landrum MB, Meara E, Ganz PA, Guadagnoli E (2005) Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector? J Natl Cancer Inst 97:257–264PubMedCrossRef
21.
22.
Zurück zum Zitat Liberatos P, Link BG, Kelsey JL (1988) The measurement of social class in epidemiology. Epidemiol Rev 10:87–121PubMed Liberatos P, Link BG, Kelsey JL (1988) The measurement of social class in epidemiology. Epidemiol Rev 10:87–121PubMed
23.
Zurück zum Zitat Liu L, Deapen D, Bernstein L (1998) Socioeconomic status and cancers of the female breast and reproductive organs: a comparison across racial/ethnic populations in Los Angeles County, California (United States). Cancer Causes Control 9:369–380. doi:10.1023/A:1008811432436 PubMedCrossRef Liu L, Deapen D, Bernstein L (1998) Socioeconomic status and cancers of the female breast and reproductive organs: a comparison across racial/ethnic populations in Los Angeles County, California (United States). Cancer Causes Control 9:369–380. doi:10.​1023/​A:​1008811432436 PubMedCrossRef
29.
Zurück zum Zitat Steensma DP, Tefferi A (2007) Risk-based management of myelodysplastic syndrome. Oncology (Williston Park) 21:43–54 (discussion 57–48, 62) Steensma DP, Tefferi A (2007) Risk-based management of myelodysplastic syndrome. Oncology (Williston Park) 21:43–54 (discussion 57–48, 62)
32.
Zurück zum Zitat Della Porta MG, Kuendgen A, Malcovati L et al (2008) Myelodysplastic Syndrome (MDS)-Specific comorbidity index for predicting the impact of extra-hematological comorbidities on survival of patients with MDS. ASH Annual Meeting Abstracts 112:2677 Della Porta MG, Kuendgen A, Malcovati L et al (2008) Myelodysplastic Syndrome (MDS)-Specific comorbidity index for predicting the impact of extra-hematological comorbidities on survival of patients with MDS. ASH Annual Meeting Abstracts 112:2677
33.
Zurück zum Zitat Pelz D, Nachtkamp K, Kündgen A, Strupp C, Haas R, Germing U (2007) C015 Influence of comorbidity factors on the prognosis of patients with myelodysplastic syndromes (MDS). Leuk Res 31:S30–S31. doi:10.1016/S0145-2126(07)70053-X CrossRef Pelz D, Nachtkamp K, Kündgen A, Strupp C, Haas R, Germing U (2007) C015 Influence of comorbidity factors on the prognosis of patients with myelodysplastic syndromes (MDS). Leuk Res 31:S30–S31. doi:10.​1016/​S0145-2126(07)70053-X CrossRef
35.
Zurück zum Zitat Do DP, Finch BK (2008) The link between neighborhood poverty and health: context or composition? Am J Epidemiol: kwn182 Do DP, Finch BK (2008) The link between neighborhood poverty and health: context or composition? Am J Epidemiol: kwn182
Metadaten
Titel
Neighborhood socioeconomic status influences the survival of elderly patients with myelodysplastic syndromes in the United States
verfasst von
Rong Wang
Cary P. Gross
Stephanie Halene
Xiaomei Ma
Publikationsdatum
01.10.2009
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 8/2009
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-009-9362-7

Weitere Artikel der Ausgabe 8/2009

Cancer Causes & Control 8/2009 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.